This application involves contain peroral dosage form of the PDE4 inhibitor as active constituent and polyvinylpyrrolidone as excipient. This application describes the dosage forms that sl. sol. 4 inhibitor of PDE is administered orally with what. They include PVP as binder.本申請涉及含有PDE4抑制劑作爲活性成分和聚乙烯吡咯烷酮作爲賦形劑的口服劑型。本申請描述了用於口服給藥微溶的PDE 4抑制劑的劑型。它們包含PVP作爲黏合劑。